Psychemedics Launches Groundbreaking Quartile Reporting for Enhanced Drug Testing Insights
Psychemedics has launched a groundbreaking Quartile Reporting feature for hair drug testing, marking an industry-first enhancement. The new feature segments test results into four quartiles – Lower, Median, Upper, and Highest – providing context for drug test results within a 12-month benchmark.
The enhancement allows organizations to see where individual candidate or employee test results rank among other positive reports, enabling more informed decision-making for workplace safety and compliance. CEO Brian Hullinger emphasizes this innovation's role in delivering more reliable and actionable drug testing solutions.
Notable features include enhanced insights for result ranking, real-time analytics for confident decision-making, and data-driven support for hiring and compliance strategies. The Quartile Reporting feature is being offered to all Psychemedics clients at no additional cost, demonstrating the company's commitment to delivering value and advancing industry standards.
Psychemedics ha lanciato una funzionalità innovativa di Reporting Quartile per il test dei capelli per droghe, segnando un miglioramento senza precedenti nel settore. La nuova funzionalità segmenta i risultati dei test in quattro quartili – Inferiore, Mediano, Superiore e Massimo – fornendo un contesto per i risultati dei test delle droghe all'interno di un benchmark di 12 mesi.
Questo miglioramento consente alle organizzazioni di vedere dove si collocano i risultati dei test di singoli candidati o dipendenti rispetto ad altri rapporti positivi, permettendo decisioni più informate per la sicurezza e la conformità sul posto di lavoro. Il CEO Brian Hullinger sottolinea il ruolo di questa innovazione nel fornire soluzioni di test delle droghe più affidabili e praticabili.
Le caratteristiche notevoli includono approfondimenti migliorati per il ranking dei risultati, analisi in tempo reale per decisioni sicure e supporto basato sui dati per strategie di assunzione e conformità. La funzionalità di Reporting Quartile è offerta a tutti i clienti di Psychemedics senza costi aggiuntivi, dimostrando l'impegno dell'azienda a fornire valore e a far progredire gli standard del settore.
Psychemedics ha lanzado una innovadora función de Informe por Cuartiles para pruebas de drogas en cabello, marcando una mejora sin precedentes en la industria. La nueva función segmenta los resultados de las pruebas en cuatro cuartiles: Inferior, Mediano, Superior y Máximo, proporcionando contexto para los resultados de las pruebas de drogas dentro de un marco de 12 meses.
Esta mejora permite a las organizaciones ver dónde se clasifican los resultados de las pruebas de candidatos o empleados individuales entre otros informes positivos, lo que permite tomar decisiones más informadas sobre la seguridad y el cumplimiento en el lugar de trabajo. El CEO Brian Hullinger enfatiza el papel de esta innovación en la entrega de soluciones de pruebas de drogas más confiables y prácticas.
Las características notables incluyen información mejorada para el ranking de resultados, análisis en tiempo real para decisiones seguras y apoyo basado en datos para estrategias de contratación y cumplimiento. La función de Informe por Cuartiles se ofrece a todos los clientes de Psychemedics sin costo adicional, demostrando el compromiso de la empresa de entregar valor y avanzar en los estándares de la industria.
사이키메딕스가 머리카락 약물 검사를 위한 혁신적인 사분위 보고서 기능을 출시하여 업계 최초의 개선을 이루었습니다. 이 새로운 기능은 테스트 결과를 네 개의 사분위로 나누어 – 하위, 중위, 상위 및 최고 – 12개월 기준 내에서 약물 검사 결과에 대한 맥락을 제공합니다.
이 개선 사항은 조직이 개별 후보자 또는 직원의 테스트 결과가 다른 긍정적인 보고서와 비교하여 어디에 위치하는지를 확인할 수 있게 하여, 직장 안전 및 준수를 위한 보다 정보에 기반한 의사 결정을 가능하게 합니다. CEO 브라이언 헐링거는 이 혁신이 보다 신뢰할 수 있고 실행 가능한 약물 검사 솔루션을 제공하는 데 중요한 역할을 한다고 강조합니다.
주요 기능으로는 결과 순위를 위한 향상된 통찰력, 확신 있는 의사 결정을 위한 실시간 분석, 그리고 채용 및 준수 전략을 위한 데이터 기반 지원이 포함됩니다. 사분위 보고서 기능은 추가 비용 없이 모든 사이키메딕스 고객에게 제공되어, 업계 표준을 발전시키고 가치를 제공하려는 회사의 의지를 보여줍니다.
Psychemedics a lancé une fonctionnalité révolutionnaire de Reporting par Quartiles pour les tests de dépistage de drogues dans les cheveux, marquant une première dans l'industrie. La nouvelle fonctionnalité segmente les résultats des tests en quatre quartiles – Inférieur, Médian, Supérieur et Maximum – fournissant un contexte pour les résultats des tests de drogues dans le cadre d'une référence de 12 mois.
Cette amélioration permet aux organisations de voir où se situent les résultats des tests d'un candidat ou d'un employé individuel par rapport à d'autres rapports positifs, permettant ainsi une prise de décision plus éclairée pour la sécurité et la conformité sur le lieu de travail. Le PDG Brian Hullinger souligne le rôle de cette innovation dans la fourniture de solutions de dépistage de drogues plus fiables et exploitables.
Les caractéristiques notables incluent des aperçus améliorés pour le classement des résultats, des analyses en temps réel pour des décisions éclairées et un soutien basé sur les données pour les stratégies de recrutement et de conformité. La fonctionnalité de Reporting par Quartiles est proposée à tous les clients de Psychemedics sans coût supplémentaire, démontrant l'engagement de l'entreprise à offrir de la valeur et à faire progresser les normes de l'industrie.
Psychemedics hat eine bahnbrechende Quartilsberichterstattung für Haar-Drogentests eingeführt, die eine branchenweit erste Verbesserung darstellt. Die neue Funktion segmentiert Testergebnisse in vier Quartile – Niedrig, Median, Hoch und Höchst – und bietet einen Kontext für Drogentest-Ergebnisse innerhalb eines 12-Monats-Benchmarks.
Diese Verbesserung ermöglicht es Organisationen zu sehen, wo die Testergebnisse einzelner Kandidaten oder Mitarbeiter im Vergleich zu anderen positiven Berichten eingestuft sind, was eine informiertere Entscheidungsfindung für Sicherheit und Compliance am Arbeitsplatz ermöglicht. CEO Brian Hullinger betont die Rolle dieser Innovation bei der Bereitstellung zuverlässiger und umsetzbarer Drogentestlösungen.
Bemerkenswerte Funktionen umfassen verbesserte Einblicke in die Ergebnisbewertung, Echtzeitanalysen für fundierte Entscheidungen und datengestützte Unterstützung für Einstellungs- und Compliance-Strategien. Die Quartilsberichterstattung wird allen Psychemedics-Kunden ohne zusätzliche Kosten angeboten und zeigt das Engagement des Unternehmens, Werte zu schaffen und die Branchenstandards voranzutreiben.
- Launch of innovative drug testing feature at no additional cost to clients
- Enhanced data analytics capabilities for client decision-making
- Competitive advantage as first-to-market with quartile reporting
- None.
DALLAS, March 03, 2025 (GLOBE NEWSWIRE) -- Psychemedics Corporation, a global leader in hair drug testing, is proud to announce the launch of its innovative Quartile Reporting feature. This industry-first enhancement empowers organizations with unprecedented insights into drug test results, enabling data-driven decision-making and fostering safer, more productive workplaces.
The new Quartile Reporting feature allows clients to see where a candidate’s or employee’s test results fall within a range of positive reports collected over the past 12 months. By segmenting results into four quartiles – Lower, Median, Upper, and Highest – this advanced reporting provides real-time context and benchmarks for substance use trends within the workforce.
“Our mission has always been to provide our clients with the most reliable and actionable drug testing solutions," said Brian Hullinger, Chief Executive Officer and President of Psychemedics. “With Quartile Reporting, we’re bringing a new level of clarity and precision to the industry, enabling organizations to better understand drug test results and make informed decisions that enhance workplace safety and compliance.”
Key Benefits of Quartile Reporting
- Enhanced Insights: Understand where individual results rank among other positives, offering valuable benchmarks for decision-making.
- Real-Time Analytics: Access up-to-date data and trends, empowering clients to act with confidence.
- Data-Driven Decisions: Use detailed context to support hiring, retention, and compliance strategies.
A Breakthrough in Workplace Drug Testing
As the drug testing landscape continues to evolve, Psychemedics is leading the way in delivering cutting-edge solutions that address the unique challenges faced by today’s employers. Quartile Reporting is part of Psychemedics’ ongoing efforts to innovate and meet the growing demand for more comprehensive, insightful drug testing data.
This enhancement is available to all Psychemedics clients at no additional cost, underscoring the company’s dedication to delivering exceptional value and driving industry advancement.
“We’re constantly striving to bring our clients tools that improve their programs and set new standards in the industry,” Brian Hullinger added. “Quartile Reporting exemplifies our commitment to innovation and our mission to empower organizations with the insights they need to thrive.”
About Psychemedics
Psychemedics Corporation is a leading global provider of innovative hair testing for drugs of abuse. With a commitment to accuracy and reliability, the company offers cutting-edge drug testing solutions. Psychemedics Corporation is dedicated to providing valuable insights and maintaining the highest standards in substance abuse testing.
Investor Relations:
Phone: 978-206-8220
Email: InvestorRelations@psychemedics.com
FAQ
What is Psychemedics' new Quartile Reporting feature for drug testing?
How will PMD's Quartile Reporting benefit employers?
Is there an additional cost for PMD's new Quartile Reporting feature?
When did PMD launch its Quartile Reporting feature?
